Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if FBIO is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
14 top institutions tracked
Sentiment: unknown
No recent insider trades detected.
Red flags: 0
55 filers reported a long position in FBIO for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $3.2M | 1M | +7.4% |
| Opaleye Management Inc. | $2.7M | 890K | -14.6% |
| MACKENZIE FINANCIAL CORP | $1.7M | 555.7K | New |
| GSA CAPITAL PARTNERS LLP | $1.4M | 458.5K | +80.4% |
| SHIKIAR ASSET MANAGEMENT INC | $935K | 305.5K | Unchanged |
| GEODE CAPITAL MANAGEMENT, LLC | $919.9K | 300.5K | +3.5% |
| BlackRock, Inc. | $687.8K | 224.8K | +14.1% |
| TWO SIGMA INVESTMENTS, LP | $654.2K | 213.8K | +8.6% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $542.7K | 177.4K | -2.7% |
| VANGUARD FIDUCIARY TRUST CO | $509.1K | 166.4K | +16.7% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.